Clinical trial
A Retrospective Cohort Study of Infusion Reactions Due to Vectibix
NCT01156090 is registered in ClinicalTrials.gov with SCRI Development Innovations, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Cohort Study of Infusion Reactions Due to Vectibix
- Lead sponsor
- SCRI Development Innovations, LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- January 31, 2013
- Enrollment
- 141 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
infusion reaction